Pacific Biosciences of California PACB Pre-Tax Income
Discontinued — last reported Q1 '26
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's pre-tax income?
- Pacific Biosciences of California (PACB) reported pre-tax income of -$8.09M in Q1 2026.
- How has Pacific Biosciences of California's pre-tax income changed year-over-year?
- Pacific Biosciences of California's pre-tax income increased by 98.1% year-over-year, from -$426.38M to -$8.09M.
- What is the long-term trend for Pacific Biosciences of California's pre-tax income?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's pre-tax income has grown at a 20.2% compound annual growth rate (CAGR), from -$314.25M to -$546.06M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.